HOME >> MEDICINE >> NEWS
COX-2 product offers good and bad news in 'test tube' strokes

Laboratory studies at Johns Hopkins have revealed that certain products of the enzymes COX-1 and COX-2 can both protect and damage the brain. The findings, published in the February 2005 issue of the Journal of Neurochemistry, offer tantalizing clues to why drugs like Vioxx and Celebrex, which block COX-2, can ease arthritis but potentially harm the heart and brain.

Katrin Andreasson, M.D., an assistant professor in the neurology and neuroscience departments at Hopkins, and lead author of the study, explains that the recent discoveries of cardiovascular complications with long-term use of some COX-2 inhibitors are thought to be due to blocking effects of "good" prostaglandins, which are the downstream products of COX activity, potentially leading to heart attacks and strokes. "Defining which prostaglandin pathways are good and which promote disease would help to design more specific therapeutics," she says.

In their latest laboratory studies, the Hopkins scientists discovered that the prostaglandin PGD2 has a protective or harmful effect in the brain depending on where it docks on a brain cell's surface. After brain cells experience the laboratory equivalent of a stroke, PDG2 can protect them from being killed if it binds to one docking point, or receptor, on the cells' surface, but causes them to die in greater numbers if it binds to a second receptor instead, the researchers report. Prostaglandins are involved in a wide variety of bodily activities including relaxation and contraction of muscles and blood vessels, control of blood pressure and inflammation.

"PGD2 is the most-produced prostaglandin in the brain," says Andreasson. "It trumps all of the rest. So we theorized that high levels are protective. But it was a surprise that it was so effective at protecting neurons."

Because the Hopkins team found that PGD2's positive effects generally outweigh its negative ones, the group speculates that PGD2 may provide a potential target
'"/>

Contact: Joanna Downer or Katherine Unger
jdowner1@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
14-Feb-2005


Page: 1 2

Related medicine news :

1. COX-2 inhibitors associated with blood pressure elevation
2. COX-2 inhibitor increases the risk of heart attack in elderly adults with no history of heart attack
3. More studies on risks and benefits of COX-2 inhibitors published in Archives of Internal Medicine
4. Special JAMA commentary on lessons learned from troubles with COX-2 inhibitors
5. NIH halts use of COX-2 inhibitor in large cancer prevention trial
6. Estrogen-associated COX-2 pathways explain protection from heart disease in female mice
7. COX-2 inhibitor could be safest anti-inflammatory drug for older people
8. Lupus discovery may pave way to better-designed COX-2 inhibitors
9. Study findings question COX-2 drug cost effectiveness
10. COX-2 inhibitors and the elderly
11. Aspirins target, the COX-2 enzyme, linked to cancer of the uterus

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... August 31, 2020 , ... Dr. Chang ... persons with autism and other developmental disabilities, as well as supporting staff in ... adolescents with autism, school consultation, and staff development. She joined the company in ...
(Date:8/29/2020)... ... ... When professor and author Randy Pausch was diagnosed with pancreatic cancer, he accepted his ... however, he put together a final lecture in Carnegie Hall in which he offered ... and turned it into something that inspired millions of people worldwide. This inclination to ...
(Date:8/28/2020)... ... August 28, 2020 , ... WHAT , ... treat patients with respiratory conditions, including COVID-19, while reducing the need for scarce ... it captures exhaled gas and scrubs it free of carbon dioxide in a ...
(Date:8/28/2020)... GROVE, Ill. (PRWEB) , ... August 28, 2020 ... ... COVID-19, The Nourished Group set out to continue helping the specialty-diet ... attendees can discover new gluten-free products, get coupons, enter giveaways, chat with brands ...
(Date:8/28/2020)... ... 28, 2020 , ... Ziegler, a specialty investment bank, is ... Synchronous Health, a tech-enabled behavioral health and well-being solutions provider. , Synchronous ... artificial intelligence (AI) to increase access and quality of behavioral health services, and ...
Breaking Medicine News(10 mins):
(Date:9/1/2020)... ... September 01, 2020 , ... While coronavirus cases continue to increase across the ... community organizations remain closed. Because about 80% of blood donations are made at drives ... donors and blood drive hosts to ensure blood products are readily available for patients. ...
(Date:8/31/2020)... ... ... you live in New York City you will always pay more for these two things: ... supply and demand, but are plastic surgeons in New York worth the premium prices that ... make the four-hour trip to have expert aesthetic treatments by some of the best doctors ...
(Date:8/28/2020)... ... August 28, 2020 , ... Dr. Mark Surrey has been in practice ... as a clinical professor in the Department of OBGYN at UCLA’s David Geffen School ... Pacific Coast Reproductive Society and is a Clinical Director of Fellowship Training for UCLA ...
Breaking Medicine Technology:
Cached News: